Ceva Completes Deal to Acquire Portfolio of Merial Swine and Cattle Vaccines and Nonsteroidal Anti-inflammatories from Boehringer Ingelheim

Food and Healthcare Press Releases Friday January 20, 2017 10:34
LIBOURNE, France--20 Jan--PRNewswire/InfoQuest

Ceva Sante Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health.

All the products will be immediately available through local Ceva companies or its distributors, with no interruption of supply.
Ceva has been consistently one of the fastest growing top 10 veterinary businesses in the last decade, investing heavily in the development of vaccines, as part of its global preventative health strategy.
Commenting on the deal, Ceva Chairman & CEO Dr. Marc Prikazsky said:

"We are delighted to acquire this range of products and strong pipeline of R&D assets.   The knowhow behind these products dates from Pasteur, Rhone-Merieux, Merial and now as Ceva we are conscious that we have a responsibility to maintain this strong veterinary scientific tradition.   Our customers can be assured that we will continue to invest to develop the products of both today and tomorrow."

ABOUT CEVA SANTE ANIMALE

Ceva Sante Animale was founded in 1999 and is a global veterinary health company, focused on research, development, production and marketing of pharmaceutical products and vaccines for companion animals, livestock, swine and poultry. Its headquarters are in Libourne (Gironde). Ceva Chairman and CEO is Marc Prikazsky.

Website: http://www.ceva.com
PRESS CONTACT
Martin Mitchell
Communication Director
+33-05-57-55-40-80
martin.mitchell@ceva.com
Company: Davidson Ryan Dore
Lawrence Dore
Lawrence.dore@drdpartnership.com
Phone: +44(0)207-520-9218
Source: Ceva Sante Animale

Latest Press Release

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

The revolutionary transport solution extends intelligent monitoring to out-of-hospital transport settings such as ambulances, helicopters, and civic flights. Mindray, a global medical equipment solution provider, announced the release of BeneVision N1...

Photo Release: Fujitsu works with the Thai Red Cross Society to contribute to society through the annual 20th FTH Voluntary Blood Donation Day

Ms. Krittinee Sivakul, Head of HR & Administration Group, Fujitsu (Thailand) Co., Ltd. (FTH) led a group comprising company management and staff at a special executives and 187 employees of the company recently donated blood to the Thai Red Cross...

Systech Europe(TM) Announces Rapid Expansion of Customer Base and Pharmaceutical Serialisation Partners Ready to Meet the FMD Regulation

Systech International , the global technology leader in serialisation, track and trace, and brand protection grew its European presence in 2017 by 50% with new accounts in France, Germany, Greece, Turkey, and Finland. The company also added new...

Fluke Biomedical VT650 and VT900 Gas Flow Analyzers offer the highest accuracy on the market

New analyzers deliver ease-of-use and reliability in measurements for all types of ventilators, flow meters, pressure gauges, anesthesia machines, and other devices Fluke Biomedical introduces the VT650 and VT900 Gas Flow Analyzers , which include...

ICS Thailand annual conference introduces new technology for breast cancer treatment.

Breast cancer is currently the most common cancer in Thai women. In order to control this deadly threat effectively, disseminating information and raising public awareness of the disease are necessary, and at the same time, medical professionals need to...

Related Topics